Healthcare Professionals
Aquamantys System
and Bipolar Sealers
Du har precis klickat på en länk som tar dig till en annan webbplats. Om du fortsätter kommer du att lämna denna webbplats och gå till en webbplats som drivs av någon annan.
Medtronic Sverige varken granskar eller kontrollerar innehållet på den andra webbplatsen och tar inget ansvar för eventuella affärstransaktioner som du utför där. Din användning av den andra webbplatsen är föremål för användarvillkoren och sekretesspolicyn på den webbplatsen.
Det är möjligt att vissa produkter på den andra platsen inte är godkända i Sverige.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
Välkommen till vår information för hälso- och sjukvårdspersonal.
Här hittar du produktinformation och annan info framtagen för dig som arbetar inom vården.
Arbetar du inom ett vårdyrke?
Healthcare Professionals
and Bipolar Sealers
The Aquamantys® System and bipolar sealers feature innovative Transcollation® technology, a combination of radiofrequency (RF) energy and saline that provides hemostatic sealing of soft tissue and bone during surgery.
Aquamantys System and Bipolar Sealers
The Aquamantys System addresses the need for surgeons to achieve hemostasis during surgery. When used during orthopaedic procedures, the Aquamantys System provides benefits for both surgeons and patients – reducing transfusion rates by minimizing intra-operative blood loss.1,2,*
Proper use of the system is important to achieve optimal results with Transcollation technology.
Use of the Aquamantys System in orthopaedic surgery provides the following clinical benefits:
The Aquamantys System consists of a generator and disposable, single-use handpieces. Medtronic Advanced Energy offers innovative Aquamantys handpieces that are adept for use in orthopaedic surgery, such as the 6.0 Bipolar Sealer and MBS Bipolar Sealer with Light. Our handpieces for hip and knee arthroplasty and orthopaedic trauma procedures offer electrode and shaft configurations designed to meet the specific needs of the surgeon.
Common orthopaedic procedures where the Aquamantys System is used include:
The Aquamantys System delivers patented Transcollation technology to stop bleeding and reduce blood loss during and after surgery.1,2,* It has been clinically shown to lower transfusion rates and significantly reduce post-operative drainage.1,2
Our patented integration of RF energy and saline delivers controlled thermal energy to tissue. This combination allows the device temperature to stay at approximately 100°C – nearly 200°C less than conventional devices, which produces a tissue effect without the charring associated with other methods.
Transcollation technology is commonly used during these procedures:
View a 3D animation of Transcollation Technology and the Aquamantys System
Performance has not been specifically established in all procedures.
Marulanda GA, Ulrich SD, et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5:125-131.
Marulanda GA, Krebs VE, et al. Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. American Journal of Orthopedics 2009; 38(12):E179-183.
Clinical Benefits of the Aquamantys System
Aquamantys bipolar sealers are used to stop bleeding and reduce blood loss during surgery.1,2,* Surgeons can achieve broad tissue-surface hemostasis by applying Transcollation technology in a painting motion or spot-treat bleeding tissue. The Aquamantys System has been shown to offer the following clinical benefits for patients when used during orthopaedic procedures:
Performance has not been specifically established in all procedures.
Length of stay has not been specifically correlated with the Aquamantys system.
Marulanda GA, Ulrich SD, Seyler TM et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5(2):125-131.
Marulanda GA, Ragland PS, Seyler TM et al. Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Tech XIV 2005; 12:281-286.
Marulanda GA, Krebs VE, Bierbaum BE et al. Hemostasis using a bipolar sealer in primary unilateral total knee arthroplasty. Am J Orthop 2009; 38(12):E179-183.
Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthrop 2007; 22(4):82-85
Covance report; 2008 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.
Medtronic Advanced Energy's patented Transcollation technology is an advanced solution that provides hemostasis during many types of surgery.
Reduced transfusion rates may lower costs to the hospital.1,† The top chart at right represents hospital national average costs for transfusions based on MedPAR data.1 Transcollation technology has been shown to provide clinical benefits and reduce transfusion rates by minimizing intra-operative blood loss in orthopaedic procedures.2,3,‡
The lower chart at right represents hospital length of stay (LOS) related to transfusions based on MedPAR data.1,* Transcollation technology has been shown to provide clinical benefits and reduce transfusion rates by minimizing intra-operative blood loss in orthopaedic procedures.2,3,‡ Transfusions are known to be a factor that increases the likelihood of post-surgical complications and can frequently contribute to increased hospital length of stay.4
We recognize that healthcare providers have various options available for managing patient hemoglobin levels perioperatively within the constraints of budget management. Medtronic is committed to delivering improved clinical outcomes while saving money for hospitals. We can work with your institution to create a customized economic analysis. Contact Medtronic Advanced Energy or your local sales representative for additional information.
Hospital length of stay has not been specifically correlated with the Aquamantys System.
Performance has not been specifically established with the Aquamantys System.
Performance has not been specifically established in all procedures.
Covance report; 2008 MedPAR database based on ICD-9-CM Codes for 100% of Medicare beneficiaries.
Marulanda GA, Ulrich SD, Seyler TM et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5(2):125-131.
Marulanda GA, Ragland PS, Seyler TM et al. Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Tech XIV 2005; 12:281-286.
Bierbaum BE, Callaghan JJ, Galante JO et al. An analysis of blood management in patients having a total hip or knee arthroplasty. J Bone & Joint Surg 1999; 81:2-10.
Performance has not been specifically established in all procedures.
Marulanda GA, Ulrich SD, Seyler TM et al. Reductions in blood loss with a bipolar sealer in total hip arthroplasty. Expert Rev Med Devices 2008; 5(2):125-131.
Marulanda GA, Ragland PS, Seyler TM et al. Reductions in blood loss with use of a bipolar sealer for hemostasis in primary total knee arthroplasty. Surg Tech XIV 2005; 12:281-286.
Rosenberg AG. Reducing blood loss in total joint surgery with a saline-coupled bipolar sealing technology. J Arthrop 2007; 22(4):82-85